BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27439498)

  • 1. Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies.
    Golsaz-Shirazi F; Mohammadi H; Amiri MM; Khoshnoodi J; Kardar GA; Jeddi-Tehrani M; Shokri F
    Arch Virol; 2016 Oct; 161(10):2765-72. PubMed ID: 27439498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
    Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
    Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.
    Golsaz Shirazi F; Mohammadi H; Amiri MM; Singethan K; Xia Y; Bayat AA; Bahadori M; Rabbani H; Jeddi-Tehrani M; Protzer U; Shokri F
    J Gastroenterol Hepatol; 2014 May; 29(5):1083-91. PubMed ID: 24325676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.
    Sloan RD; Ijaz S; Moore PL; Harrison TJ; Teo CG; Tedder RS
    Antivir Ther; 2008; 13(3):439-47. PubMed ID: 18572757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and expression of hepatitis B surface antigen escape variants within the "a" determinant by site directed mutagenesis.
    Golsaz Shirazi F; Amiri MM; Mohammadi H; Bayat AA; Roohi A; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Kardar GA; Shokri F
    Iran J Immunol; 2013 Sep; 10(3):127-38. PubMed ID: 24076590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential reactivity of mouse monoclonal anti-HBs antibodies with recombinant mutant HBs antigens.
    Roohi A; Yazdani Y; Khoshnoodi J; Jazayeri SM; Carman WF; Chamankhah M; Rashedan M; Shokri F
    World J Gastroenterol; 2006 Sep; 12(33):5368-74. PubMed ID: 16981270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping of recombinant hepatitis B surface antigen by murine monoclonal antibodies.
    Roohi A; Khoshnoodi J; Zarnani AH; Shokri F
    Hybridoma (Larchmt); 2005 Apr; 24(2):71-7. PubMed ID: 15857170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
    Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
    Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
    Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of murine monoclonal antibodies targeting different epitopes of the hepatitis B virus surface antigen by using immunological as well as molecular biology and biochemical approaches.
    Alves Vianna CO; da Silva E Mouta Júnior S; da Glória Teixeira Martins M; Batoreu NM; Queiroz JL; Gomes SA; Magalhães de Andrade Góes AC; Garcia Armoa GR; Marques CH; Baroni de Moraes MT
    J Immunol Methods; 2006 Jun; 313(1-2):38-47. PubMed ID: 16753174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity pattern of monoclonal antibodies against Hepatitis B vaccine with global Hepatitis B virus genotypes.
    Golsaz-Shirazi F; Asadi-Asadabad S; Sarvnaz H; Mehdi Amiri M; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Shokri F
    Clin Chim Acta; 2020 Nov; 510():203-210. PubMed ID: 32679130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characterization of Murine Monoclonal Antibody Variable Regions Specific for Hepatitis B Surface Antigen.
    Golsaz-Shirazi F; Amiri MM; Bahadori M; Bayat AA; Mohammadi H; Farid S; Maddah M; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Shokri F
    Viral Immunol; 2015 Oct; 28(8):425-33. PubMed ID: 26425894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen.
    Tian Y; Xu Y; Zhang Z; Meng Z; Qin L; Lu M; Yang D
    J Clin Microbiol; 2007 Sep; 45(9):2971-8. PubMed ID: 17609325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis.
    Maillard P; Pillot J
    Res Virol; 1998; 149(3):153-61. PubMed ID: 9711539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of anti-HBsAg epitope monoclonal antibodies and establishment of a sandwich ELISA for HBV serotype detection].
    Zhang X; Nie Y; Lan X; Li Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):171-5. PubMed ID: 24491059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of group-specific a antigen in hepatitis B vaccines by anti-HBs/a monoclonal antibody.
    Yamamoto H; Satoh T; Kiyohara T; Totsuka A; Moritsugu Y
    Biologicals; 1997 Dec; 25(4):373-80. PubMed ID: 9467033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies.
    Jolivet-Reynaud C; Lésenéchal M; O'Donnell B; Becquart L; Foussadier A; Forge F; Battail-Poirot N; Lacoux X; Carman W; Jolivet M
    J Med Virol; 2001 Oct; 65(2):241-9. PubMed ID: 11536229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype.
    Sobotta D; Sominskaya I; Jansons J; Meisel H; Schmitt S; Heermann KH; Kaluza G; Pumpens P; Gerlich WH
    J Gen Virol; 2000 Feb; 81(Pt 2):369-78. PubMed ID: 10644835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.